Trials / Unknown
UnknownNCT05083936
Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The overall goal of this imaging trial is to prospectively compare the usefulness of 18F-FDG PET and 18F-FET PET in evaluating treatment response and predicting prognosis in patients with central nervous system lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [18F]FET | Imaging evaluation using LAT1/4F2hc substrate overexpressed in brain tumor |
Timeline
- Start date
- 2021-08-27
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
- First posted
- 2021-10-19
- Last updated
- 2021-10-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05083936. Inclusion in this directory is not an endorsement.